Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FOV2304 in Diabetic Macular Edema
NCT01319487Phase 2Completed
- Sponsor
- Fovea Pharmaceuticals
- Start
- May 2011
- Primary completion
- Mar 2012
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 2 trial of safotibant in diabetic macular edema (DME), sponsored by Fovea Pharmaceuticals. Started May 2011; status: completed.
02
Drugs
safotibant
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT01319487.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01319487.